Cargando…
Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management
Perianal fistulizing Crohn’s Disease (pCD) affects about 25% of patients with Crohn’s Disease (CD). It remains a difficult entity to manage with a therapeutic ceiling of treatment success despite improving medical and surgical management. The refractory nature of the disease calls for an imminent ne...
Autores principales: | Anandabaskaran, Sulak, Hanna, Luke, Iqbal, Nusrat, Constable, Laura, Tozer, Phil, Hart, Ailsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573672/ https://www.ncbi.nlm.nih.gov/pubmed/37835022 http://dx.doi.org/10.3390/jcm12196379 |
Ejemplares similares
-
Medical and surgical management of perianal Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2018) -
Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017) -
Managing complex perianal disease after anti-TNF failure: Where to go next?
por: Yzet, Clare, et al.
Publicado: (2022) -
Advances in digital CBT: where are we now, and where next?
por: Thew, Graham R., et al.
Publicado: (2022) -
The future of high-grade glioma: Where we are and where are we going
por: Rhun, Emilie Le, et al.
Publicado: (2015)